These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35346107)

  • 1. Prognostic significance of SNCA and its methylation in bladder cancer.
    Wu Z; Xia C; Zhang C; Yang D; Ma K
    BMC Cancer; 2022 Mar; 22(1):330. PubMed ID: 35346107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Song DM; Shen T; Feng K; He YB; Chen SL; Zhang Y; Luo WF; Han L; Tong M; Jin Y
    Front Immunol; 2024; 15():1419126. PubMed ID: 39234248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
    Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
    Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer.
    Xu PH; Chen S; Wang Y; Jin S; Wang J; Ye D; Zhu X; Shen Y
    Comput Biol Med; 2023 Aug; 162():106976. PubMed ID: 37301098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global analysis of miRNA-mRNA regulation pair in bladder cancer.
    Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Wang T; Zhu W
    World J Surg Oncol; 2022 Mar; 20(1):66. PubMed ID: 35241117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of
    Lin B; Zhang T; Ye X; Yang H
    Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
    Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y
    PeerJ; 2023; 11():e15284. PubMed ID: 37123010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HYAL3 as a potential novel marker of BLCA patient prognosis.
    Liu JP; Fang YT; Jiang YF; Lin H
    BMC Genom Data; 2022 Aug; 23(1):63. PubMed ID: 35945500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
    Pan W; Liu X; Liu S
    Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Shared Gene Signatures and Molecular Mechanisms between Bladder Urothelial Carcinoma and Metabolic Syndrome.
    Li C; Wan Z; Deng Q; Li Z; Wang Y
    Arch Esp Urol; 2023 Oct; 76(8):605-621. PubMed ID: 37960960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
    Liu M; Chen S; Zhang A; Zheng Q; Fu J
    J Inflamm Res; 2021; 14():4629-4641. PubMed ID: 34552345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer.
    Wu S; Qiu S; Chen W; Ding L; Wu L
    Dis Markers; 2022; 2022():5081413. PubMed ID: 36263004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration.
    Zhou Z; Zhou Y; Zhou X; Huang Y; Cui Y; Zhang Y
    J Oncol; 2022; 2022():1146186. PubMed ID: 35799606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylated ITGA8 Facilitate Bladder Cancer Cell Proliferation and Metastasis.
    Ma X; Zhang L; Liu L; Ruan D; Wang C
    Appl Biochem Biotechnol; 2024 Jan; 196(1):245-260. PubMed ID: 37119505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
    Li H; Zhang Y; Zheng S
    Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.